@WHO: Interleukin-6 receptor blockers are a class of medicines that are lifesaving in patients who are severely or critically ill with #COVID19, especially when administered alongside corticosteroids. 👉https://t.co/Y0GvhsxMXw https://t.co/9gb1S0Ai45

http://twitter.com/WHO
via IFTTT